NYSEArca - Delayed Quote USD

ALPS Medical Breakthroughs ETF (SBIO)

34.09 -0.44 (-1.28%)
At close: May 17 at 3:58 PM EDT
Loading Chart for SBIO
DELL
  • Previous Close 34.53
  • Open 34.42
  • Bid 30.91 x 1200
  • Ask 34.75 x 900
  • Day's Range 34.09 - 34.42
  • 52 Week Range 23.21 - 38.80
  • Volume 1,659
  • Avg. Volume 11,887
  • Net Assets 104.95M
  • NAV 34.09
  • PE Ratio (TTM) --
  • Yield 0.22%
  • YTD Daily Total Return 3.48%
  • Beta (5Y Monthly) 0.87
  • Expense Ratio (net) 0.50%

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

ALPS

Fund Family

Health

Fund Category

104.95M

Net Assets

2014-12-30

Inception Date

Performance Overview: SBIO

Trailing returns as of 5/17/2024. Category is Health.

YTD Return

SBIO
3.48%
Category
0.45%
 

1-Year Return

SBIO
7.24%
Category
1.63%
 

3-Year Return

SBIO
9.21%
Category
3.64%
 

People Also Watch

Holdings: SBIO

Top 10 Holdings (33.71% of Total Assets)

SymbolCompany% Assets
VKTX
Viking Therapeutics, Inc. 5.57%
CERE
Cerevel Therapeutics Holdings, Inc. 5.17%
PCVX
Vaxcyte, Inc. 4.37%
RVMD
Revolution Medicines, Inc. 4.09%
ALPN
Alpine Immune Sciences, Inc. 2.82%
ALKS
Alkermes plc 2.73%
AXSM
Axsome Therapeutics, Inc. 2.33%
SWTX
SpringWorks Therapeutics, Inc. 2.30%
CRNX
Crinetics Pharmaceuticals, Inc. 2.28%
XENE
Xenon Pharmaceuticals Inc. 2.04%

Sector Weightings

SectorSBIO
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: SBIO

Research Reports: SBIO

Related Tickers